Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Aixue Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Psoriasis, Dermatitis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
A recent study confirmed that thiolutin (THL), as a potent inflammasome inhibitor, plays a promising therapeutic role in multiple inflammatory disease models. However, the effect of THL on psoriasis has not been reported so far.
Methods
A psoriasiform dermatitis model was prepared by applying 5% imiquimod (IMQ) cream on mice. A total of 36 mice were randomly divided into six groups: control, model, model + THL‐L/M/H (THL, 1/2.5/5 mg/kg/day), model + methotrexate (1 mg/kg/day). Psoriasis area and severity index (PASI) scores were observed and calculated. The histological changes in skin, liver, and kidney tissues were observed by hematoxylin and eosin staining. Alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and blood creatinine were measured by automatic biochemistry analyzer. The size of the spleens was determined, and the proportion of Foxp3 + CD4+ regulatory T (Treg) cells in the spleens was tested by flow cytometry. The proinflammatory factors and nucleotide oligomerization domain nucleotide oligomerization domain (NOD)‐like receptor protein 3 (NLRP3) inflammasome protein levels were examined by reverse transcription‐quantitative polymerase chain reaction, enzyme‐linked immunosorbent assay, Western blotting, and immunohistochemistry, respectively.
Results
THL administration preeminently reduced the thickness, scaling, and erythema of the skin lesions, alleviated IMQ‐induced psoriasiform lesions in mice, reduced the PASI score, and ameliorated histopathological changes in mouse skin. The spleen index was decreased by almost half and the proportion of Foxp3 + CD4+ Treg cells was increased after intervention by THL. THL intervention did not affect liver and kidney function, but decreased the expression levels of proinflammatory factors and NLRP3 inflammasome in the skin of psoriatic mice.
Conclusions
THL may alleviate IMQ‐induced psoriasis‐like manifestations in mice by inhibiting NLRP3 inflammasome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
ORCID-Profile: Huanhuan Zhang
Zitieren
APA
Wang, A., Ma, X., Wei, F., Li, Y., Liu, Q., & Zhang, H. (2023). Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.877
Vancouver
Wang A, Ma X, Wei F, Li Y, Liu Q, Zhang H. Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.877
BibTeX
@article{Wang2023,
author = {Wang, Aixue and Ma, Xixing and Wei, Feng and Li, Yanling and Liu, Qiang and Zhang, Huanhuan},
title = {Evidence on the therapeutic role of thiolutin in imiquimod‐induced psoriasis‐like skin inflammation in mice},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.877}
}
EUVIMED